Reaction
Application Site Scar reporting signals
As of the last recalculation, Application Site Scar appears in 1,238 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is GLYCERIN, LIDOCAINE (PRR 132.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Glycerin, Lidocaine | 101 | 132.0 | 132.9 |
| Docosanol | 101 | 126.1 | 126.9 |
| Buprenorphine | 200 | 43.1 | 43.2 |
| Nicotine | 59 | 25.7 | 25.7 |
| Estradiol | 111 | 23.6 | 23.7 |
| Nicotine Polacrilex Mini | 17 | 19.3 | 19.3 |
| Nicotine Polarilex | 17 | 19.3 | 19.3 |
| Nicotine Polacrilex | 30 | 13.5 | 13.5 |
| Estradiol Gel 0.1% | 28 | 10.6 | 10.6 |
| Estradiol Transdermal | 28 | 10.6 | 10.6 |
| Rotigotine | 9 | 10.5 | 10.5 |
| Oxybutynin | 14 | 8.1 | 8.1 |
| Fentanyl Citrate | 6 | 5.7 | 5.7 |
| Minoxidil Foam 5% (Womens) | 9 | 4.6 | 4.6 |
| Minoxidil | 10 | 3.8 | 3.8 |
| Salicylic Acid | 4 | 1.3 | 1.3 |